Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
Dutch court grants Novo Nordisk injunction against unlawful compounded semaglutide nasal spray, reinforcing patient safety and IP rights.
Covered in this story
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.